Latest Daily Edition Stories

If Doctors Use Your Data To Develop Treatments, Do They Need To Tell You?

Ethicists, patients, doctors and courts are wrestling with that question as efforts grow to expand care through better data and technology. Also, Stat offers a guide to CRISPR, and Madrigal Pharmaceuticals says one of its drugs has shown progress treating fatty liver disease.

Doctors Are Prescribing Fewer Opioids, Says AMA

The number of opioid prescriptions in the U.S. dropped 22 percent between 2013 and 2017, leading to an estimated 55 million fewer scripts, according to the doctors’ group. These numbers are part of the American Medical Association’s argument against proposed federal clinical practice legislation. Also in the news, an exposé on the marketing techniques used by some corners of big pharma regarding these medicines. Meanwhile, updates on California’s experiment in distributing fentanyl tests.

When CEO Pay Is Corrected, The Number Can Be Dramatic

In other health industry news, Allergan announced it will sell its women’s health, infectious-disease units, as well as a voluntary recall of nearly 170,000 birth control packs because of a packaging error that could lead to unintended pregnancy.